Management of Drug-Drug Interactions among Critically Ill Patients with Chronic Kidney Disease: Impact of Clinical Pharmacist's Interventions.

Background And Objectives: Drug-drug interactions (DDIs) can create a burden on prescribers to preserve patient safety. This study aimed to identify common DDIs in critically ill patients with chronic kidney disease (CKD) and to evaluate clinical pharmacist's interventions in managing DDIs among these patients.

Methods: A prospective observational study was conducted from October 2018 to March 2019.

A clinical pharmacist-led integrated approach for evaluation of medication errors among medical intensive care unit patients.

Aim: Medication errors jeopardize the safety of critically ill patients. Using only one method for the detection of medication errors may not reflect an existing picture of patient safety accurately. Therefore, we designed a clinical pharmacist-led integrated approach to evaluate incidence rate, type, and severity of medication errors and preventable adverse drug events (ADEs) and to assess the impact of the implementation of interventions recommended by the clinical pharmacist.

Pharmaceutical Excipient Exposure in a Neonatal Intensive Care Unit.

Objective: To study the excipients exposure among neonates in a neonatal intensive care unit.

Method: Prospective observational study was conducted from January, 2017 to June, 2019. Details of administered drugs were collected from the hospital case files.

Identifying characteristics of drug-related problems in critically ill patients with decompensated liver cirrhosis.

Objectives: Characteristics of drug-related problems and related patient harm has not been evaluated in critically ill patients with decompensated cirrhosis. Our objectives were to identify characteristics and incidence rate of drug-related problems and related preventable harm in critically ill patients with decompensated liver cirrhosis.

Patients And Methods: A prospective observational study was conducted from February 2018 to January 2019 in 10-bed medical intensive care unit of a tertiary care hospital.

Risk factors and management of diabetic nephropathy.

To determine the risk factors for nephropathy in diabetic patients and to study the management of diabetic nephropathy (DN), we conducted a hospital-based prospective study in the Internal Medicine department of our hospital on 60 patients with DN and 60 diabetic patients without DN. An odds ratio (OR) disclosed the following risk factors: Hypertension (OR = 2.06), family history of diabetes (OR = 1.